(Q40976667)

25 September 2017

title

Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis (English)

1 reference

25 September 2017

Pi-Yueh Chang

1

1 reference

25 September 2017

Cheng-Tao Yang

series ordinal

2

1 reference

25 September 2017

Ching-Hui Cheng

series ordinal

3

1 reference

25 September 2017

Kuang-Hui Yu

series ordinal

4

1 reference

25 September 2017

publication date

4 May 2015

1 reference

International Journal of Rheumatic Diseases

25 September 2017

published in

1 reference

25 September 2017

volume

19

1 reference

25 September 2017

issue

9

1 reference

25 September 2017

page(s)

880-886

1 reference

Rheumatoid arthritis: Uncoupling bone and cartilage destruction

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Rheumatic diseases in North America's indigenous peoples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Autoantibodies in rheumatoid arthritis and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis in a Chinese population: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Reporting of precision of estimates for diagnostic accuracy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Clinical utility of the anti-CCP assay: experiences with 700 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12552

21 January 2018

Identifiers

DOI

10.1111/1756-185X.12552

1 reference

25 September 2017

1 reference